Literature DB >> 9467943

Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice.

P E Blackshear1, S M Goldsworthy, J F Foley, K A McAllister, L M Bennett, N K Collins, D O Bunch, P Brown, R W Wiseman, B J Davis.   

Abstract

The mouse homologues of the breast cancer susceptibility genes, Brca1 and Brca2, are expressed in a cell cycle-dependent fashion in vitro and appear to be regulated by similar or overlapping pathways. Therefore, we compared the non isotopic in situ hybridization expression patterns of Brca1 and Brca2 mRNA in vivo in mitotic and meiotic cells during mouse embryogenesis, mammary gland development, and in adult tissues including testes, ovaries, and hormonally altered ovaries. Brca1 and Brca2 are expressed concordantly in proliferating cells of embryos, and the mammary gland undergoing morphogenesis and in most adult tissues. The expression pattern of Brca1 and Brca2 correlates with the localization of proliferating cell nuclear antigen, an indicator of proliferative activity. In the ovary, Brca1 and Brca2 exhibited a comparable hormone-independent pattern of expression in oocytes, granulosa cells and thecal cells of developing follicles. In the testes, Brca1 and Brca2 were expressed in mitotic spermatogonia and early meiotic prophase spermatocytes. Northern analyses of prepubertal mouse testes revealed that the time course of Brca2 expression was delayed in spermatogonia relative to Brca1. Thus, while Brca1 and Brca2 share concordant cell-specific patterns of expression in most proliferating tissues, these observations suggest that they may have distinct roles during meiosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9467943     DOI: 10.1038/sj.onc.1201506

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

Review 1.  Expression of BRCA1 and BRCA2 in normal and neoplastic cells.

Authors:  L A Chodosh
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

2.  Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1.

Authors:  X Liu; D F Barker
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

Review 3.  Characteristics, causes and evolutionary consequences of male-biased mutation.

Authors:  Hans Ellegren
Journal:  Proc Biol Sci       Date:  2007-01-07       Impact factor: 5.349

4.  A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent.

Authors:  M Vooijs; J Jonkers; A Berns
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

5.  Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice.

Authors:  V L Cressman; D C Backlund; A V Avrutskaya; S A Leadon; V Godfrey; B H Koller
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 6.  Developmental studies of Brca1 and Brca2 knock-out mice.

Authors:  R Hakem; J L de la Pompa; T W Mak
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

7.  Transcriptional regulation of BRCA1 expression by a metabolic switch.

Authors:  Li-Jun Di; Alfonso G Fernandez; Adriana De Siervi; Dan L Longo; Kevin Gardner
Journal:  Nat Struct Mol Biol       Date:  2010-11-21       Impact factor: 15.369

8.  Breast cancer 1 (BrCa1) may be behind decreased lipogenesis in adipose tissue from obese subjects.

Authors:  Francisco J Ortega; José M Moreno-Navarrete; Dolores Mayas; Eva García-Santos; María Gómez-Serrano; José I Rodriguez-Hermosa; Bartomeu Ruiz; Wifredo Ricart; Francisco J Tinahones; Gema Frühbeck; Belen Peral; José M Fernández-Real
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

9.  Homologs of breast cancer genes in plants.

Authors:  Oliver Trapp; Katharina Seeliger; Holger Puchta
Journal:  Front Plant Sci       Date:  2011-06-20       Impact factor: 5.753

10.  Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.

Authors:  Elizabeth M Swisher; Rachel M Gonzalez; Toshiyasu Taniguchi; Rochelle L Garcia; Tom Walsh; Barbara A Goff; Piri Welcsh
Journal:  Mol Cancer       Date:  2009-07-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.